Swiss National Bank’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-127,700
| Closed | -$1.15M | – | 2611 |
|
|
2016
Q3 | $1.15M | Sell |
127,700
-4,900
| -4% | -$34.8K | ﹤0.01% | 1881 |
|
|
2016
Q2 | $712K | Buy |
132,600
+7,200
| +6% | +$36.9K | ﹤0.01% | 2161 |
|
|
2016
Q1 | $557K | Buy |
125,400
+24,700
| +25% | +$99.3K | ﹤0.01% | 2248 |
|
|
2015
Q4 | $524K | Hold |
100,700
| – | – | ﹤0.01% | 2238 |
|
|
2015
Q3 | $609K | Buy |
100,700
+15,400
| +18% | +$189K | ﹤0.01% | 2073 |
|
|
2015
Q2 | $1.35M | Buy |
85,300
+10,000
| +13% | +$121K | ﹤0.01% | 1599 |
|
|
2015
Q1 | $819K | Buy |
75,300
+2,600
| +4% | +$26.5K | ﹤0.01% | 1876 |
|
|
2014
Q4 | $765K | Hold |
72,700
| – | – | ﹤0.01% | 1890 |
|
|
2014
Q3 | $697K | Hold |
72,700
| – | – | ﹤0.01% | 1883 |
|
|
2014
Q2 | $840K | Hold |
72,700
| – | – | ﹤0.01% | 1825 |
|
|
2014
Q1 | $727K | Buy |
72,700
+18,100
| +33% | +$261K | ﹤0.01% | 1901 |
|
|
2013
Q4 | $711K | Buy |
54,600
+9,300
| +21% | +$128K | ﹤0.01% | 1768 |
|
|
2013
Q3 | $677K | Hold |
45,300
| – | – | ﹤0.01% | 1730 |
|
|
2013
Q2 | $424K | Buy |
+45,300
| New | +$307K | ﹤0.01% | 2031 |
|
Swiss National Bank's RPTP Position: Q4 2016 in Review
Swiss National Bank sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 127,700 shares — an estimated $1.15M sold.
Swiss National Bank first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $1.35M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Swiss National Bank reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Swiss National Bank sold 127,700 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.15M.
- Swiss National Bank first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- Swiss National Bank's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.35M in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Swiss National Bank's 13F filing for Q4 2016, filed 8 Feb 2017.